Is Bloom Energy The Best Stock to Buy Now?
Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…
Buy
56
APNHY Quote, Financials, Valuation and Earnings
Last price:
$5.68
Seasonality move
:
6.44%
Day range:
$5.68 - $5.68
52-week range:
$5.24 - $10.14
Dividend yield:
2.13%
P/E ratio:
12.64x
P/S ratio:
1.06x
P/B ratio:
0.62x
Volume:
3
Avg. volume:
1.3K
1-year change:
-40.89%
Market cap:
$2.5B
Revenue:
$2.4B
EPS (TTM):
-$0.13
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Aspen Pharmacare Holdings Ltd. has -- downside to fair value with a price target of -- per share.
APNHY vs. S&P 500
-
Over the past 5 trading days, Aspen Pharmacare Holdings Ltd. has overperformed the S&P 500 by 2.51% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Aspen Pharmacare Holdings Ltd. does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Aspen Pharmacare Holdings Ltd. has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Aspen Pharmacare Holdings Ltd. reported revenues of --.
Earnings Growth
-
Aspen Pharmacare Holdings Ltd. earnings have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Aspen Pharmacare Holdings Ltd. reported earnings per share of --.
Enterprise value:
4.4B
EV / Invested capital:
--
Price / LTM sales:
1.06x
EV / EBIT:
9.90x
EV / Revenue:
1.75x
PEG ratio (5yr expected):
--
EV / Free cash flow:
396.28x
Price / Operating cash flow:
445.95x
Enterprise value / EBITDA:
9.90x
Gross Profit (TTM):
$1.1B
Return On Assets:
3.33%
Net Income Margin (TTM):
-2.33%
Return On Equity:
5.41%
Return On Invested Capital:
3.81%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2011-12-31 | 2012-12-31 | 2013-12-31 | 2012-12-31 | 2013-12-31 | |
| Income Statement | ||||||
| Revenue | $1.9B | $2B | $2.3B | $1.1B | $1.1B | |
| Gross Profit | $883.4M | $952.6M | $1B | $515.2M | $530.3M | |
| Operating Income | $481M | $530.3M | $585.3M | $293.2M | $273.8M | |
| EBITDA | $541.1M | $590.8M | $652.9M | $293.2M | $273.8M | |
| Diluted EPS | $0.73 | $0.80 | $0.85 | $0.43 | $0.40 | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $2.3B | $2.1B | $2.4B | $2.3B | -- | |
| Total Assets | $7.6B | $6.9B | $7.2B | $7.4B | -- | |
| Current Liabilities | $2.6B | $1.4B | $1.2B | $1.3B | -- | |
| Total Liabilities | $3.1B | $2.5B | $2.6B | $2.9B | -- | |
| Total Equity | $4.6B | $4.4B | $4.6B | $4.5B | -- | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2011-12-31 | 2012-12-31 | 2013-12-31 | 2012-12-31 | 2013-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $419.4M | $361.8M | $393.3M | $155.2M | $111.8M | |
| Cash From Investing | -$942.2M | -$708.1M | -$1.7B | -$443.9M | -$1.4B | |
| Cash From Financing | $370.9M | $366.6M | $2B | $312.4M | $1.9B | |
| Free Cash Flow | $270.2M | -$329.4M | $262.5M | -$288.3M | $10.6M | |
APNHY
Sector
Market Cap
$2.5B
$27.9M
Price % of 52-Week High
56.02%
51.04%
Dividend Yield
2.13%
0%
Shareholder Yield
3.17%
-1.49%
1-Year Price Total Return
-40.9%
-16.66%
Beta (5-Year)
0.778
0.516
Dividend yield:
2.13%
Annualized payout:
$0.21
Payout ratio:
156.39%
Growth streak:
1 years
Technicals
8-day SMA
Buy
Level
$5.50
200-day SMA
Sell
Level
$6.56
Bollinger Bands (100)
Sell
Level
5.42 - 6.08
Chaikin Money Flow
Sell
Level
-1.1M
20-day SMA
Buy
Level
$5.44
Relative Strength Index (RSI14)
Buy
Level
60.97
ADX Line
Buy
Level
15.3
Williams %R
Sell
Level
-10.8108
50-day SMA
Buy
Level
$5.56
MACD (12, 26)
Buy
Level
0.02
25-day Aroon Oscillator
Buy
Level
68
On Balance Volume
Sell
Level
-941.7K
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (1.907)
Buy
CA Score
(Annual)
Level (0.4406)
Buy
Beneish M-Score
(Annual)
Level (-2.5172)
Sell
Momentum Score
Level (2)
Buy
Ohlson Score
Level (-3.7395)
Buy
Piotroski F Score
(Annual)
Level (5)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Aspen Pharmacare Holdings Ltd. manufactures and supplies branded and generic pharmaceutical products. It operates through the Commercial Pharmaceuticals and Manufacturing segments. The Commercial Pharmaceuticals segment consists of the following business sub segments: Sterile Focused Brands, which includes the Anaesthetics and Thrombosis portfolios; and Regional Brands, which are products that are managed on a regional basis. The Manufacturing segment focuses on the following business sub segments: Active Pharmaceutical Ingredients, which involved in API Chemicals business and non-heparin biochemical API business; Heparin, which refers to the full value chain contribution from all heparin containing products; FDF Steriles, which includes all FDF sterile sales; and FDF Other, which consists of all non-sterile FDF products. The company was founded by Michael Guy Attridge and Stephen Bradley Saad in 1850 and is headquartered in Durban, South Africa.
Stock Forecast FAQ
In the current month, APNHY has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The APNHY average analyst price target in the past 3 months is --.
-
Where Will Aspen Pharmacare Holdings Ltd. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Aspen Pharmacare Holdings Ltd. share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Aspen Pharmacare Holdings Ltd.?
Analysts are divided on their view about Aspen Pharmacare Holdings Ltd. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Aspen Pharmacare Holdings Ltd. is a Sell and believe this share price will rise from its current level to --.
-
What Is Aspen Pharmacare Holdings Ltd.'s Price Target?
The price target for Aspen Pharmacare Holdings Ltd. over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is APNHY A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Aspen Pharmacare Holdings Ltd. is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of APNHY?
You can purchase shares of Aspen Pharmacare Holdings Ltd. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Aspen Pharmacare Holdings Ltd. shares.
-
What Is The Aspen Pharmacare Holdings Ltd. Share Price Today?
Aspen Pharmacare Holdings Ltd. was last trading at $5.68 per share. This represents the most recent stock quote for Aspen Pharmacare Holdings Ltd.. Yesterday, Aspen Pharmacare Holdings Ltd. closed at $5.68 per share.
-
How To Buy Aspen Pharmacare Holdings Ltd. Stock Online?
In order to purchase Aspen Pharmacare Holdings Ltd. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get APNHY Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
APNHY
Sector
P/E ratio
12.64x
23.85x
PEG ratio
--
-0.01x
P/B ratio
0.62x
1.81x
Price / LTM sales
1.06x
1.58x
Growth Metrics
APNHY
Sector
Revenue growth
--
4.62%
Earnings growth
--
10.5%
Revenue (5-year growth)
2.14%
6.5%
Earnings forecast
--
-$0.21
Profitability
APNHY
Sector
Profitability FY 2025
$1B
$3.6M
Return on invested capital
3.81%
-31.87%
Return on assets
3.33%
-28.18%
Return on equity
5.41%
-37.63%
Earnings Date
Last Earnings Date
Sep
3
Next Earnings Date
Mar
3
Estimated Next Earnings Date
Dec
3
Balance Sheet
APNHY
Sector
Total cash
$361.9M
$26.4M
Short term investments
--
$25.7M
Total assets
$7.6B
$76.9M
Long term debt
--
$3.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Berkshire Hathaway Stock Undervalued?
Berkshire Hathaway (NYSE:BRK.A,BRK.B) has undershot the market this year, returning…
Is Oracle Stock Undervalued?
Shares of Oracle (NYSE:ORCL) rocketed higher earlier this year when…
Stock Ideas
Buy
54
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
57
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 38x
Alerts
Sell
1
LW alert for Dec 20
Lamb Weston Holdings, Inc. [LW] is down 25.96% over the past day.
Buy
54
BMRN alert for Dec 20
BioMarin Pharmaceutical, Inc. [BMRN] is up 17.79% over the past day.
Buy
82
RKLB alert for Dec 20
Rocket Lab Corp. [RKLB] is up 17.72% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
